Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: May 14, 2026

RNA Fluorescence In Situ Hybridization for Long Non-Coding RNA Localization in Human Osteosarcoma Cells

RNA Fluorescence In Situ Hybridization for Long Non-Coding RNA Localization in Human Osteosarcoma Cells

Published on: June 16, 2023

Array comparative genomic hybridization in osteosarcoma.

Bekim Sadikovic¹, Paul C Park, Shamini Selvarajah

¹Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA, sadikovic@hhsc.ca.

Methods in Molecular Biology (Clifton, N.J.)

|February 16, 2013

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Segmental Copy Number Variant Detection Using an Amplicon-based NGS Panel for Integrated Glioma Classification.

The Journal of molecular diagnostics : JMD·2026

Same author

De novo EHMT2 variants cause an autosomal dominant EHMT2-related Kleefstra syndrome via loss of G9a methyltransferase activity.

Nature communications·2026

Same author

Delineating the clinical and molecular spectrum of the neurodevelopmental disorder associated with SET.

Genetics in medicine : official journal of the American College of Medical Genetics·2026

Same author

Correction: Chromatinopathies: clinically overlapping disorders, revealing novel variants and their DNA methylation signatures.

Clinical epigenetics·2026

Same author

Biallelic inactivating variants in the chromatin remodeler DMAP1 cause a syndromic neurodevelopmental disorder.

The Journal of clinical investigation·2026

Same author

Episignature leads to diagnosis and reclassification of DYRK1A variant in a child with syndromic neurodevelopmental disorder: a case report.

Frontiers in genetics·2026

Same journal

Tracking Synthetic Adhesins on Bacterial Surfaces with Immunofluorescence Microscopy.

Methods in molecular biology (Clifton, N.J.)·2026

Same journal

Post-Selection Methods for Analyzing mRNA Display Selections and Optimization of Hits.

Methods in molecular biology (Clifton, N.J.)·2026

Same journal

High-Performance Computing in Tandem Mass Spectrometry (MS/MS) Peptide Identification.

Methods in molecular biology (Clifton, N.J.)·2026

Same journal

Engineering and Adapting Disulfide-Containing Proteins to Enable Intracellular Functionality.

Methods in molecular biology (Clifton, N.J.)·2026

Same journal

AI-Driven Protein Research: From Prediction to Design.

Methods in molecular biology (Clifton, N.J.)·2026

Same journal

Methods for the In Vitro Selection of Protein and Peptide Libraries Using mRNA Display.

Methods in molecular biology (Clifton, N.J.)·2026

See all related articles

Array comparative genomic hybridization (aCGH) reveals complex genomic alterations in osteosarcoma, a primary bone cancer. This technology aids in identifying molecular targets and prognostic markers for improved osteosarcoma treatment strategies.

Area of Science:

Oncology
Genetics
Genomics

Background:

Osteosarcoma is the most common primary bone tumor, predominantly affecting young individuals.
It is characterized by aggressive local and systemic progression and chaotic aneuploid karyotypes.
Familial genetics has identified tumor suppressor genes (RB1, TP53) and DNA repair genes (RECQL4) implicated in osteosarcoma etiology.

Purpose of the Study:

To provide an overview of osteosarcoma clinical features and subtypes.
To detail array comparative genomic hybridization (aCGH) methods for osteosarcoma analysis.
To review aCGH studies, discuss emerging genes, molecular mechanisms, and clinical implications.

Main Methods:

Review of clinical features and subtypes of conventional osteosarcoma.

More Related Videos

Methods to Enable Spatial Transcriptomics of Bone Tissues

Methods to Enable Spatial Transcriptomics of Bone Tissues

Published on: May 3, 2024

Array Comparative Genomic Hybridization (Array CGH) for Detection of Genomic Copy Number Variants

Array Comparative Genomic Hybridization (Array CGH) for Detection of Genomic Copy Number Variants

Published on: February 21, 2015

Related Experiment Videos

Last Updated: May 14, 2026

RNA Fluorescence In Situ Hybridization for Long Non-Coding RNA Localization in Human Osteosarcoma Cells

RNA Fluorescence In Situ Hybridization for Long Non-Coding RNA Localization in Human Osteosarcoma Cells

Published on: June 16, 2023

Methods to Enable Spatial Transcriptomics of Bone Tissues

Methods to Enable Spatial Transcriptomics of Bone Tissues

Published on: May 3, 2024

Array Comparative Genomic Hybridization (Array CGH) for Detection of Genomic Copy Number Variants

Array Comparative Genomic Hybridization (Array CGH) for Detection of Genomic Copy Number Variants

Published on: February 21, 2015

Overview of materials and analytical methods for osteosarcoma aCGH.

Literature review of aCGH studies and integrative genomics in osteosarcoma.

Main Results:

aCGH provides insights into the mechanisms generating complex osteosarcoma genomes.
Genomic profiling elucidates tumor development, evolution, and identifies potential prognostic markers.
Emerging genes and molecular mechanisms are being identified with clinical implications.

Conclusions:

aCGH is a valuable tool for understanding osteosarcoma genomics.
This approach aids in identifying therapeutic targets and prognostic markers.
Integrative genomics offers further potential for advancing osteosarcoma research and treatment.